• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

越南经皮冠状动脉介入治疗登记研究的建立:原理与方法。

Establishment of a Percutaneous Coronary Intervention Registry in Vietnam: Rationale and Methodology.

机构信息

School of Public Health, Curtin University, Perth, AU.

Thai Nguyen University of Medicine and Pharmacy, Thai Nguyen, VN.

出版信息

Glob Heart. 2020 Apr 8;15(1):30. doi: 10.5334/gh.782.

DOI:10.5334/gh.782
PMID:32489803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7218793/
Abstract

BACKGROUND

In lower- and middle-income countries across Asia there has been a rapid expansion and uptake of percutaneous coronary intervention (PCI). However, there has been limited routine collection of related data, particularly around quality, safety and cost. The aim of this study was to assess the viability of implementing routine collection of PCI data in a registry at a leading hospital in Hanoi, Vietnam.

METHOD

A Vietnamese data collection form and collection strategy were developed in collaboration with the Vietnam National Heart Institute. Information on patient characteristics, treatments, and outcomes was collected through direct interviews using a standardised form and medical record abstraction, while PCI data was read and coded into paper forms by interventional cardiologists. Viability of the registry was determined by four main factors: 1) being able to collect a representative sample; 2) quality of data obtained; 3) costs and time taken for data collection by hospital staff; and 4) level of support from key stakeholders in the institute.

RESULTS

Between September 2017 and May 2018, 1,022 patients undergoing PCI were recruited from a total of 1,041 procedures conducted during that time frame. The estimated mean time to collect information from patients before discharge was 60 minutes. Of the collected data fields, 98% were successfully completed. Most hospital staff surveyed indicated support for the continuation of the activity following the implementation of the pilot study.

CONCLUSIONS

The proposed methodology for establishing a PCI registry in a large hospital in Vietnam produced high quality data and was considered worthwhile by hospital staff. The model has the potential opportunity for replication in other cardiac catheterisation sites, leading to a national PCI registry in Vietnam.

摘要

背景

在亚洲的中低收入国家,经皮冠状动脉介入治疗(PCI)迅速扩张并得到采用。然而,在质量、安全和成本方面,相关数据的常规收集非常有限。本研究旨在评估在越南河内一家领先医院实施 PCI 数据常规收集的可行性。

方法

与越南国家心脏研究所合作,制定了越南数据收集表和收集策略。通过使用标准化表格和病历摘要对患者特征、治疗和结果进行直接访谈,同时由介入心脏病专家读取和将 PCI 数据编码到纸质表格中,来收集信息,而 PCI 数据则由介入心脏病专家读取和编码到纸质表格中。该注册的可行性通过以下四个主要因素来确定:1)能够收集有代表性的样本;2)获得的数据质量;3)医院工作人员收集数据的成本和时间;4)研究所内关键利益相关者的支持程度。

结果

2017 年 9 月至 2018 年 5 月,从该时间段内总共进行的 1041 次 PCI 中,共招募了 1022 名接受 PCI 的患者。估计在出院前从患者处收集信息的平均时间为 60 分钟。在所收集的数据字段中,98%的字段成功完成。大多数接受调查的医院工作人员表示,在实施试点研究后,他们支持继续开展该活动。

结论

在越南一家大型医院建立 PCI 注册的拟议方法产生了高质量的数据,并且得到了医院工作人员的认可。该模型有可能在其他心脏导管插入站点复制,从而在越南建立一个全国性的 PCI 注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c0/7218793/1dd1d651f3ad/gh-15-1-782-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c0/7218793/1dd1d651f3ad/gh-15-1-782-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c0/7218793/1dd1d651f3ad/gh-15-1-782-g1.jpg

相似文献

1
Establishment of a Percutaneous Coronary Intervention Registry in Vietnam: Rationale and Methodology.越南经皮冠状动脉介入治疗登记研究的建立:原理与方法。
Glob Heart. 2020 Apr 8;15(1):30. doi: 10.5334/gh.782.
2
Novel insights into clinical characteristics and in-hospital outcomes of patients undergoing percutaneous coronary intervention in Vietnam.越南接受经皮冠状动脉介入治疗患者的临床特征和院内结局的新见解。
Int J Cardiol Heart Vasc. 2020 Sep 4;31:100626. doi: 10.1016/j.ijcha.2020.100626. eCollection 2020 Dec.
3
Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: A report from the National Cardiovascular Data Registry CathPCI Registry.择期经皮冠状动脉介入治疗稳定型冠状动脉疾病患者:来自全国心血管数据注册中心经皮冠状动脉介入治疗注册库的报告。
Am Heart J. 2019 Oct;216:53-61. doi: 10.1016/j.ahj.2019.07.004. Epub 2019 Jul 13.
4
Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States.经皮冠状动脉介入治疗的 Medicare 受益患者中与入路部位相关的成本和当日出院:对美国当前经皮冠状动脉介入治疗护理路径的评估。
JACC Cardiovasc Interv. 2017 Feb 27;10(4):342-351. doi: 10.1016/j.jcin.2016.11.049.
5
Contemporary Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in the United States: An Analysis of the National Cardiovascular Data Registry Research to Practice Initiative.当代美国无保护左主干冠状动脉经皮冠状动脉介入治疗的应用和趋势:国家心血管数据注册研究实践倡议分析。
JAMA Cardiol. 2019 Feb 1;4(2):100-109. doi: 10.1001/jamacardio.2018.4376.
6
Demographics and Outcomes of Percutaneous Coronary Intervention in Thailand: Data from Thai Percutaneous Coronary Intervention Registry.泰国经皮冠状动脉介入治疗的人口统计学和结果:来自泰国经皮冠状动脉介入治疗注册中心的数据。
J Med Assoc Thai. 2017 Mar;100(3):270-9.
7
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.经皮冠状动脉介入治疗开口/中段病变与无保护左主干冠状动脉分叉病变的长期临床结局:DELTA 注册研究(左主干冠状动脉疾病药物洗脱支架):一项多中心注册研究,评估经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干的疗效。
JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
8
Clinical characteristics and in hospital outcomes of heart transplant recipients with allograft vasculopathy undergoing percutaneous coronary intervention: Insights from the National Cardiovascular Data Registry.接受经皮冠状动脉介入治疗的心脏移植受者合并移植血管病变的临床特征及院内结局:来自国家心血管数据注册库的见解
Am Heart J. 2015 Dec;170(6):1086-91. doi: 10.1016/j.ahj.2015.09.021. Epub 2015 Oct 3.
9
Improving Guideline Compliance in Australia With a National Percutaneous Coronary Intervention Outcomes Registry.通过全国经皮冠状动脉介入治疗结果登记处提高澳大利亚的指南依从性。
Heart Lung Circ. 2017 Dec;26(12):1303-1309. doi: 10.1016/j.hlc.2017.01.008. Epub 2017 Feb 28.
10
Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry.经皮冠状动脉介入治疗后急性肾损伤患者不良事件的纵向风险:来自国家心血管数据登记处的见解
Circ Cardiovasc Interv. 2017 Apr;10(4). doi: 10.1161/CIRCINTERVENTIONS.116.004439.

引用本文的文献

1
Quality of Life in Patients Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗患者的生活质量
Clin Pract. 2023 May 17;13(3):621-637. doi: 10.3390/clinpract13030057.
2
Sex differences in quality of life of patients following percutaneous coronary intervention in Vietnam.越南经皮冠状动脉介入治疗患者生活质量的性别差异。
Qual Life Res. 2023 Jan;32(1):71-79. doi: 10.1007/s11136-022-03237-5. Epub 2022 Aug 29.
3
Access route selection for percutaneous coronary intervention among Vietnamese patients: Implications for in-hospital costs and outcomes.

本文引用的文献

1
Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control.《2000 - 2016年全球心血管疾病地图集:预防与控制之路》
Glob Heart. 2018 Sep;13(3):143-163. doi: 10.1016/j.gheart.2018.09.511. Epub 2018 Oct 6.
2
Demographics and Outcomes of Percutaneous Coronary Intervention in Thailand: Data from Thai Percutaneous Coronary Intervention Registry.泰国经皮冠状动脉介入治疗的人口统计学和结果:来自泰国经皮冠状动脉介入治疗注册中心的数据。
J Med Assoc Thai. 2017 Mar;100(3):270-9.
3
The Establishment of the Victorian Cardiac Outcomes Registry (VCOR): Monitoring and Optimising Outcomes for Cardiac Patients in Victoria.
越南患者经皮冠状动脉介入治疗的通路选择:对住院费用和治疗结果的影响。
Lancet Reg Health West Pac. 2021 Mar 2;9:100116. doi: 10.1016/j.lanwpc.2021.100116. eCollection 2021 Apr.
4
Novel insights into clinical characteristics and in-hospital outcomes of patients undergoing percutaneous coronary intervention in Vietnam.越南接受经皮冠状动脉介入治疗患者的临床特征和院内结局的新见解。
Int J Cardiol Heart Vasc. 2020 Sep 4;31:100626. doi: 10.1016/j.ijcha.2020.100626. eCollection 2020 Dec.
维多利亚心脏结局注册系统(VCOR)的建立:监测与优化维多利亚州心脏病患者的治疗结局
Heart Lung Circ. 2018 Apr;27(4):451-463. doi: 10.1016/j.hlc.2017.07.013. Epub 2017 Oct 12.
4
The design and rationale of the primary angioplasty registry of Kerala.喀拉拉邦原发性血管成形术登记处的设计与基本原理。
Indian Heart J. 2017 Nov-Dec;69(6):777-783. doi: 10.1016/j.ihj.2017.05.025. Epub 2017 May 31.
5
Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) retrospective study of coronary catheterisation and percutaneous coronary intervention.中国心脏事件以患者为中心的评估(China PEACE)冠状动脉导管插入术和经皮冠状动脉介入治疗回顾性研究方案。
BMJ Open. 2014 Mar 7;4(3):e004595. doi: 10.1136/bmjopen-2013-004595.
6
The Asia-Pacific Evaluation of Cardiovascular Therapies (ASPECT) collaboration --improving the quality of cardiovascular care in the Asia Pacific region.亚太心血管治疗评估(ASPECT)合作组织——提高亚太地区心血管护理质量。
Int J Cardiol. 2014 Mar 1;172(1):72-5. doi: 10.1016/j.ijcard.2013.12.030. Epub 2013 Dec 22.
7
Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia.澳大利亚导管消融治疗心房颤动与冠状动脉介入治疗缺血性心脏病的十年趋势比较。
Europace. 2013 Dec;15(12):1702-9. doi: 10.1093/europace/eut162. Epub 2013 Jun 24.
8
Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations.按国家/地区和年龄划分的缺血性心脏病死亡率:世界卫生组织和联合国的统计数据。
Int J Cardiol. 2013 Sep 30;168(2):934-45. doi: 10.1016/j.ijcard.2012.10.046. Epub 2012 Dec 4.
9
The journey of Malaysian NCVD-PCI (National Cardiovascular Disease Database-Percutaneous Coronary Intervention) Registry: a summary of three years report.马来西亚 NCVD-PCI(国家心血管疾病数据库-经皮冠状动脉介入治疗)注册研究的历程:三年报告总结。
Int J Cardiol. 2013 Apr 30;165(1):161-4. doi: 10.1016/j.ijcard.2011.08.015. Epub 2011 Sep 15.
10
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.心血管临床试验的标准化出血定义:出血学术研究联盟的共识报告。
Circulation. 2011 Jun 14;123(23):2736-47. doi: 10.1161/CIRCULATIONAHA.110.009449.